Article
NNV024, a novel humanized anti-CD37 antibody with enhanced ADCC and prolonged plasma…
medRxiv · 2023 · Generaloc, R.; Fiorito, E.; Foss, S.; Pascal, V.; Heyerdahl, H.; Repetto, A.; Andersen, J. T.; Tjonnfjord, G.; Skanland, S. S.; Dahle, J.
Key facts
| Title | NNV024, a novel humanized anti-CD37 antibody with enhanced ADCC and prolonged plasma half-life in human FcRn transgenic mice for treatment of NHL |
|---|---|
| First author | Generaloc, R.; Fiorito, E.; Foss, S.; Pascal, V.; Heyerdahl, H.; Repetto, A.; Andersen, J. T.; Tjonnfjord, G.; Skanland, S. S.; Dahle, J. |
| Journal | medRxiv |
| Published | Jul 12, 2023 |
| DOI | 10.1101/2023.07.12.548667 |
| Devices mentioned | DEN000008, K022086, K103302, K800781, K982382 |
| Product codes mentioned | CFN, KIS, NDS, DEW, JCI, KIT, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1